CMS Corrects 2012 HCPCS Level II File
- By admin aapc
- In Billing
- February 10, 2012
- Comments Off on CMS Corrects 2012 HCPCS Level II File
The Centers for Medicare & Medicaid Services (CMS) released 25 corrections to the 2012 HCPCS Level II ANWEB file. The corrections, released Jan. 30, include description and ambulatory surgery center (ASC) indicator changes, removal of codes, updated Berenson-Eggers Type of Service (BETOS) information, and revised effective dates.
Terminated or Removed
C9716 Creations of thermal anal lesions by radiofrequency energy should be terminated effective Jan. 1, 2012.
G0449 Annual face-to-face obesity screening, 15 minutes will not be created. Remove from file.
G0450 Screening for sexually transmitted infections, includes laboratory tests for chlamydia, gonorrhea, syphilis and hepatitis B will not be created. Remove from file.
Revised Descriptions
G0446 Long description Intensive behavioral therapy to reduce cardiovascular disease risk, individual, fact-to-face, >annual<, 15 minutes is revised effective Nov. 8, 2011.
G8553 Both short description (Prescrip transmit via ERx sy) and long description (Prescription(s) generated and transmitted via a qualified ERx system) are changed effective Jan. 1, 2012.
J1561 Short description Gamunex, Gamunex-C, Gammaked is changed effective Jan. 1, 2012.
Revised Effective Dates
G0442 Annual alcohol misuse screening, 15 minutes is now effective Oct. 14, 2011.
G0443 Brief face-to-face behavior counseling for alcohol misuses, 15 minutes is also effective Oct. 14, 2011.
K0743 Suction pump, home model, portable, for use on wounds is now effective July 1, 2011.
Revised Indicators
C1886 Catheter, extravascular tissue ablation, any modality (insertable)—Add ASC “YY” indicator, effective Jan. 1, 2012.
C9728 Placement of endorectal intracavitary applicator for high intensity brachytherapy—Add ASC “YY” indicator, effective Jan. 1, 2008.
C9732 Insertion of ocular telescope prosthesis including removal of crystalline lens—Add ASC “YY” indicator, effective Jan. 1, 2012.
G0448 Insertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber with insertion of pacing electrode, cardiac venous system, for left ventricular pacing—Change TOS to “2,” effective Jan. 1, 2012.
J2265 Injection, minocycline hydrochloride, 1 mg—Remove ASC “YY” indicator, effective Jan. 1, 2012.
Q4123 Alloskin RT, per sq cm—Remove ASC “YY” indicator, effective Jan. 1, 2012.
Q4125 Arthroflex, per sq cm—Remove ASC “YY” indicator, effective Jan. 1, 2012.
Q4126 Memoderm, per sq cm—Remove ASC “YY” indicator, effective Jan. 1, 2012.
Q4127 Talymed, per sq cm—Remove ASC “YY” indicator, effective Jan. 1, 2012.
Q4128 FlexHD or Allopatch HD, per sq cm—Remove ASC “YY” indicator, effective Jan. 1, 2012.
Q4129 Unite biomatrix, per sq cm—Remove ASC “YY” indicator, effective Jan. 1, 2012.
J8561 Everolimus, oral 0.25, mg—Change BETOS to “01E,” effective Jan. 1, 2012.
CMS recommends updating data files as well as noting changes in codebooks.
- Correctly Identify Low Back Pain - March 1, 2023
- How to Optimize the RCM Process - February 1, 2023
- It Pays to Participate in AAPC’s Annual Salary Survey - September 1, 2022
800-626-2633
